Frank Erhard Uschner Selected Research

Frank Erhard Uschner Research Topics

Disease

17	Fibrosis (Cirrhosis) 02/2024 - 01/2017
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2017
7	Portal Hypertension 01/2023 - 01/2017
6	Non-alcoholic Fatty Liver Disease 02/2024 - 01/2019
6	Acute-On-Chronic Liver Failure 01/2024 - 01/2020
5	Liver Diseases (Liver Disease) 01/2024 - 05/2017
4	End Stage Liver Disease 12/2021 - 01/2017
4	Inflammation (Inflammations) 03/2020 - 05/2017
3	Ascites 12/2021 - 01/2017
2	Infections 02/2024 - 01/2020
2	Weight Loss (Weight Reduction) 02/2024 - 10/2020
2	Morbid Obesity 10/2020 - 03/2020
2	Obesity 05/2020 - 03/2020
2	Peritonitis 01/2020 - 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2023
1	Sarcopenia 08/2023
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023
1	Hepatic Encephalopathy 12/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Hemorrhage 11/2020
1	Body Weight (Weight, Body) 03/2020
1	Rhabdomyolysis 01/2020
1	Hypovolemia 01/2020
1	Hepatorenal Syndrome 01/2020
1	Alcoholic Fatty Liver 01/2019
1	Pulmonary Hypertension 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2017
1	Thrombosis (Thrombus) 05/2017
1	Varicose Veins (Varicose Vein) 01/2017

Drug/Important Bio-Agent (IBA)

3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2021
2	NitratesIBA 02/2024 - 01/2018
2	Janus Kinase 2IBA 01/2023 - 12/2019
2	Ethanol (Ethyl Alcohol)IBA 01/2023 - 01/2019
2	InflammasomesIBA 01/2021 - 01/2021
2	AlbuminsIBA 01/2021 - 01/2020
2	ReninIBA 05/2020 - 12/2019
2	Human Serum Albumin FDA LinkGeneric 01/2020 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 05/2017
2	Rho Guanine Nucleotide Exchange FactorsIBA 12/2019 - 01/2017
2	rho-Associated KinasesIBA 01/2019 - 01/2017
2	Transaminases (Aminotransferases)IBA 11/2018 - 01/2018
1	TerlipressinIBA 02/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2024
1	NitritesIBA 02/2024
1	Hypoxia-Inducible Factor 1IBA 01/2024
1	galacturonic acidIBA 08/2023
1	hexanoylcarnitineIBA 08/2023
1	MyostatinIBA 08/2023
1	Drinking WaterIBA 01/2023
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 12/2021
1	NitrogenIBA 12/2021
1	Alanine Transaminase (SGPT)IBA 12/2021
1	LipopolysaccharidesIBA 01/2021
1	nasIBA 10/2020
1	Interleukin-22 (IL-22)IBA 10/2020
1	oil red OIBA 05/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 03/2020
1	AdipokinesIBA 03/2020
1	AdiponectinIBA 03/2020
1	Blood Glucose (Blood Sugar)IBA 03/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2020
1	LeptinIBA 03/2020
1	Triglycerides (Triacylglycerol)IBA 03/2020
1	Rifaximin (L 105)FDA Link 01/2020
1	Drug CombinationsIBA 01/2020
1	Simvastatin (Zocor)FDA LinkGeneric 01/2020
1	AVE 0991IBA 12/2019
1	MetalsIBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Thromboxane B2IBA 01/2019
1	Prostaglandin D2IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	matrigelIBA 11/2018
1	regorafenibIBA 11/2018
1	riociguatIBA 01/2018
1	CholesterolIBA 05/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 01/2017
1	Angiotensin IIIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017

Therapy/Procedure

4	Ligation 01/2021 - 01/2017
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 02/2024 - 01/2019
2	Therapeutics 02/2024 - 11/2018
2	Transjugular Intrahepatic Portasystemic Shunt 02/2024 - 01/2020
2	Bariatric Surgery 02/2024 - 10/2020
1	Liver Transplantation 01/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2020
1	Gastrectomy 03/2020
1	Stents 01/2019
1	Secondary Prevention 05/2017
1	Transplantation 05/2017
1	Microspheres (Microsphere) 01/2017